Ensysce Biosciences, Inc. (ENSC)
NASDAQ·Healthcare·Biotechnology
$0.38
+0.08%
Mkt Cap $1.27M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $502.97K | $1.90M | +277.76% | -$1.26 | -$0.75 | +40.48% | — | — |
| Q4 2025 Nov 14, 2025 | $700.00K | $493.10K | -29.56% | -$0.85 | -$1.29 | -51.76% | — | — |
| Q3 2025 Aug 13, 2025 | $1.40M | $1.37M | -1.96% | -$1.02 | -$0.79 | +22.55% | — | — |
| Q2 2025 May 13, 2025 | — | $1.32M | — | -$3.02 | -$1.39 | +53.97% | — | — |
| Q1 2025 Mar 10, 2025 | $245.00K | $1.30M | +432.24% | -$2.74 | -$2.90 | -5.84% | — | — |
| Q4 2024 Nov 12, 2024 | $245.00K | $3.42M | +1295.45% | -$4.50 | $1.05 | +123.33% | — | — |
| Q3 2024 Aug 14, 2024 | $300.00K | $181.80K | -39.40% | -$5.85 | -$3.30 | +43.59% | — | — |
| Q2 2024 May 10, 2024 | $400.00K | $305.72K | -23.57% | -$13.49 | -$8.25 | +38.84% | — | — |
| Q1 2024 Mar 15, 2024 | $250.00K | $515.03K | +106.01% | -$12.89 | -$16.94 | -31.42% | — | — |
| Q4 2023 Nov 9, 2023 | $390.00K | $435.38K | +11.64% | -$15.89 | -$13.04 | +17.94% | — | — |
| Q3 2023 Aug 11, 2023 | $830.00K | $490.47K | -40.91% | -$40.93 | -$14.69 | +64.11% | — | — |
| Q2 2023 May 15, 2023 | $950.00K | $789.63K | -16.88% | -$208.55 | -$31.18 | +85.05% | — | — |
| Q1 2023 Mar 30, 2023 | $960.00K | $1.43M | +49.27% | -$466.15 | -$273.57 | +41.31% | — | — |
| Q4 2022 Nov 14, 2022 | $1.54M | $279.35K | -81.86% | -$539.95 | -$923.31 | -71.00% | — | — |
| Q3 2022 Aug 11, 2022 | $1.00M | $207.47K | -79.25% | -$755.92 | -$863.91 | -14.29% | — | — |
| Q2 2022 May 12, 2022 | $1.20M | $603.10K | -49.74% | -$719.93 | -$719.93 | +0.00% | — | — |
| Q1 2022 Mar 31, 2022 | $800.00K | $1.64M | +104.38% | $323.97 | -$1619.84 | -600.00% | — | — |
| Q4 2021 Nov 15, 2021 | — | $1.20M | — | — | -$2555.74 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | $444.52K | — | — | -$215.98 | — | — | — |
| Q2 2021 Jun 8, 2021 | — | $250.58K | — | — | -$8.98 | — | — | — |